Evidence map›Paper›PMID 38429997›Full record

SynthesisJournal of the National Cancer Institute2024

Dietary interventions in cancer: a systematic review of all randomized controlled trials.

Nosakhare Paul Ilerhunmwuwa, Abul Hasan Shadali Abdul Khader, Calvin Smith, Edward R Scheffer Cliff, Christopher M Booth, Evevanne Hottel, Muhammad Aziz, Wade Lee-Smith, Aaron Goodman, Rajshekhar Chakraborty and 1 more

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Journal of the National Cancer Institute, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Health-related quality of life in esophageal cancer: a state-of-the-art review of patient-reported outcomes and an evidence and gap map.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2025
    Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 3 countries.

Nosakhare Paul IlerhunmwuwaOne Brooklyn Health/Brookdale University Hospital and Medical Center, Brooklyn, NY, USA.ORCID 0000-0002-4950-5611
Abul Hasan Shadali Abdul KhaderGovernment Kilpauk Medical College, Chennai, Tamil Nadu, India.ORCID 0000-0001-5628-3829
Calvin SmithFrank H. Netter MD School of Medicine, Quinnipiac University, North Haven, CT, USA.ORCID 0009-0005-0061-6459
Edward R Scheffer CliffProgram on Regulation, Therapeutics and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-5977-907X
Christopher M BoothDivision of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, ON, Canada.ORCID 0000-0002-1353-3653
Evevanne HottelDivision of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Muhammad AzizDivision of Gastroenterology and Hepatology, University of Toledo, Toledo, OH, USA.
Wade Lee-SmithMulford Health Science Library, University of Toledo, Toledo, OH, USA.ORCID 0000-0003-1744-8525
Aaron GoodmanDivision of Blood and Marrow Transplantation, University of California San Diego, San Diego, CA, USA.
Rajshekhar ChakrabortyDivision of Hematology, Columbia University Cancer Center, New York, NY, USA.ORCID 0000-0001-7336-3003
Ghulam Rehman MohyuddinDivision of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-6464-783X
University of Toledo · USUniversity of Utah · USBrigham and Women's Hospital · USBrookdale University Hospital and Medical Center · USColumbia University Irving Medical Center · USGovernment Kilpauk Medical College · INQueen's University · CAQuinnipiac University · USUniversity of California San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrior systematic reviews addressing the impact of diet on cancer outcomes have focused on specific dietary interventions. In this systematic review, we assessed all randomized controlled trials (RCTs) investigating dietary interventions for cancer patients, examining the range of interventions, endpoints, patient populations, and results.

methodsThis systematic review identified all RCTs conducted before January 2023 testing dietary interventions in patients with cancer. Assessed outcomes included quality of life, functional outcomes, clinical cancer measurements (eg, progression-free survival, response rates), overall survival, and translational endpoints (eg, inflammatory markers).

resultsIn total, 252 RCTs were identified involving 31 067 patients. The median sample size was 71 (interquartile range 41 to 118), and 80 (32%) studies had a sample size greater than 100. Most trials (n = 184, 73%) were conducted in the adjuvant setting. Weight or body composition and translational endpoints were the most common primary endpoints (n = 64, 25%; n = 52, 21%, respectively). Direct cancer measurements and overall survival were primary endpoints in 20 (8%) and 7 (3%) studies, respectively. Eight trials with a primary endpoint of cancer measurement (40%) met their endpoint. Large trials in colon (n = 1429), breast (n = 3088), and prostate cancer (n = 478) each showed no effect of dietary interventions on endpoints measuring cancer.

conclusionMost RCTs of dietary interventions in cancer are small and measure nonclinical endpoints. Although only a small number of large RCTs have been conducted to date, these trials have not shown an improvement in cancer outcomes. Currently, there is limited evidence to support dietary interventions as a therapeutic tool in cancer care.

Indexed as

NeoplasmsRandomized Controlled Trials as TopicDietHumansQuality of Life

Identifiers

PMID38429997
PMCPMC11223872
OpenAlexW4392401568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.